Lili Yao Selected Research

olutasidenib

1/2020

Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lili Yao Research Topics

Disease

10	Neoplasms (Cancer) 04/2024 - 01/2018
2	COVID-19 10/2023 - 09/2022
2	Ovarian Neoplasms (Ovarian Cancer) 03/2023 - 02/2020
2	Insulin Resistance 09/2021 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2018
2	Infections 01/2021 - 01/2018
2	Carcinogenesis 02/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2012
2	Inflammation (Inflammations) 01/2016 - 01/2014
1	Vomiting 10/2023
1	Nausea 10/2023
1	Fever (Fevers) 10/2023
1	Acid-Base Imbalance 02/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Follicular Adenocarcinoma 01/2023
1	Common Cold 09/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022
1	Pneumonia (Pneumonitis) 03/2022
1	Hemorrhage 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Hypertension (High Blood Pressure) 11/2021
1	Adenocarcinoma of Lung 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Ulcerative Colitis 01/2021
1	AIDS-Related Complex (ARC) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2019
1	Adenocarcinoma 09/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Body Weight (Weight, Body) 01/2016
1	Hyperglycemia 01/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 02/2012
3	EnzymesIBA 01/2018 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2020
2	pembrolizumabIBA 01/2023 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 09/2021 - 01/2020
2	Exenatide (Byetta)FDA Link 09/2021 - 01/2020
2	AcidsIBA 01/2021 - 02/2012
2	MicroRNAs (MicroRNA)IBA 02/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 02/2020 - 01/2004
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 04/2024
1	P-SelectinIBA 04/2024
1	polydopamineIBA 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 04/2024
1	VaccinesIBA 10/2023
1	C-Reactive ProteinIBA 10/2023
1	CyclinsIBA 03/2023
1	Sulfur DioxideIBA 02/2023
1	FluoridesIBA 02/2023
1	Sodium-Bicarbonate SymportersIBA 02/2023
1	Sodium Fluoride (Ossin)FDA Link 02/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	CREB-Binding ProteinIBA 01/2023
1	ElementsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	16S Ribosomal RNAIBA 01/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 05/2022
1	Rituximab (Mabthera)FDA Link 03/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2021
1	GasotransmittersIBA 11/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021
1	Long Noncoding RNAIBA 01/2021
1	CateninsIBA 01/2021
1	shenling baizhu sanIBA 01/2021
1	LipidsIBA 01/2021
1	Sterol Regulatory Element Binding ProteinsIBA 01/2021
1	WortmanninIBA 01/2021
1	fibroblast growth factor 21IBA 01/2020
1	isophane insulin lispro drug combination (25:75) insulin lisproIBA 01/2020
1	Monoamine Oxidase (MAO)IBA 01/2020
1	CopperIBA 01/2020
1	alpha-hydroxyglutarateIBA 01/2020
1	SiliconIBA 01/2020
1	TitaniumIBA 01/2020
1	olutasidenibIBA 01/2020
1	hydrogen sulfite (bisulfite)IBA 09/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2018
1	GlycogenIBA 01/2018
1	arseniteIBA 01/2018
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 01/2018
1	Liver GlycogenIBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	LeptinIBA 01/2016

Therapy/Procedure

5	Therapeutics 04/2024 - 09/2021
1	Drug Therapy (Chemotherapy) 04/2024
1	Oral Administration 03/2023
1	Neoadjuvant Therapy 01/2023
1	Patient Isolation 09/2022